JUL 30, 2020 2:21 PM PDT

Cats Successfully Treated with Gene Therapy

WRITTEN BY: Annie Lennon

While gene therapy is a promising treatment for multiple diseases caused by a genetic mutation, getting gene therapy agents beyond the brain-blood barrier- the brain's protective layer- is a challenge. Now, researchers from the University of Pennsylvania may have found a solution. 

Gene therapy works by delivering a functional version of a gene inside a virus- known as a viral vector- to a mutated version. In doing so, the functional version overrides the mutated version's effects and theoretically corrects the condition. While steady progress has been made in correcting neurogenetic diseases in rodents, applying the same treatments in larger mammals has only partially worked. 

In this new study, the researchers used cats to assess the efficacy of gene therapy to treat alpha-mannosidosis. The condition occurs naturally in cats from a mutated copy of the alpha-mannosidase gene. To assess whether their new gene therapy would work, they injected it into the cats' carotid artery for direct delivery to the brain. Cats either received a high or low dose of the vector. 

In the end, the researchers found that treated cats had a significantly delayed onset of certain neurological symptoms and a longer lifespan. They also noted that those on higher doses tended to live the longest. 

"It's a big advance," says John Wolfe, lead author of the study. "Nobody has been able to treat the whole brain of a large-brained animal before. We're hopeful that this will translate into clinical use in humans."

Although promising results, Wolfe cautions that the treatment did not cure the cats of their condition- although it did improve their symptoms. He added that they do not know whether the therapy impacted their mental ability. Thus, before any conclusions can be made about the treatment, further research is needed from more animal studies. 

 

Sources: Medical XpressOxford Academic

About the Author
  • Science writer with keen interests in technology and behavioral biology. Her current focus is on the interplay between these fields to create meaningful interactions, applications and environments.
You May Also Like
JAN 01, 2021
Microbiology
A New Type of Antibiotics Help the Immune System Fight Pathogens
JAN 01, 2021
A New Type of Antibiotics Help the Immune System Fight Pathogens
Reporting in Nature, scientists have identified a new group of compounds that may help us get out of the antibiotic-resi ...
JAN 27, 2021
Drug Discovery & Development
Do Vaccines Work Against New Covid Variants?
JAN 27, 2021
Do Vaccines Work Against New Covid Variants?
The SARS-CoV-2 virus is mutating faster than scientists previously thought. As such, pharmaceutical companies are now sc ...
JAN 26, 2021
Drug Discovery & Development
Gut Microbiota Reveals Drug Activity
JAN 26, 2021
Gut Microbiota Reveals Drug Activity
Inflammatory bowel diseases cannot be entirely cured but instead, the symptoms are treated with anti-inflammat ...
APR 06, 2021
Infographics
Psychedelic Medicine 101
APR 06, 2021
Psychedelic Medicine 101
As clinical trials for psychedelics progress, interest in psychedelics is increasing among pharmaceutical firms, clinici ...
APR 06, 2021
Immunology
Lymphoma Patient Cured by "Reeducating" their Immune System
APR 06, 2021
Lymphoma Patient Cured by "Reeducating" their Immune System
Australian researchers have used a breakthrough therapy to cure a patient diagnosed with a rare brain lymphoma, a form o ...
APR 02, 2021
Technology
Protein Modeling of SARS-CoV-2 Provides Targets for Vaccine Development
APR 02, 2021
Protein Modeling of SARS-CoV-2 Provides Targets for Vaccine Development
Recent protein modeling of the SARS-CoV-2 spike protein reveals novel areas for vaccine development. The novel SARS-CoV- ...
Loading Comments...